<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Preterm Labor and Birth - National Guidelines</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
        MathJax = {
            tex: {
                inlineMath: [['$', '$'], ['\\(', '\\)']],
                displayMath: [['$$', '$$'], ['\\[', '\\]']],
                processEscapes: true,
                processEnvironments: true,
                tags: 'ams'
            },
            svg: { fontCache: 'global' },
            options: {
                skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
            }
        };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>

<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">üè†</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="04-aph-and-pprom.html" class="nav-button">
                        <span class="nav-icon">‚Üê</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 27%;"></div>
                        </div>
                        <span class="progress-text">Section 5 of 18</span>
                    </div>
                    <a href="06-medical-disorders-hypertension.html" class="nav-button">
                        <span class="nav-text">Next: Hypertensive Disorders</span>
                        <span class="nav-icon">‚Üí</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">PRETERM LABOR</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">

                <!-- START: preterm-labor-definition -->
                <section id="preterm-labor-definition" class="content-section">
                    <h2>Definition</h2>
                    <div class="content-card">
                        <p>Preterm labour denotes regular uterine contractions accompanied by progressive cervical
                            dilation with or without effacement at less than 37 weeks of gestation.</p>
                        <p>Preterm birth occurs between 24- and 37weeks gestation. In two-thirds of cases it occurs
                            following spontaneous onset of labour. Only a minority of women who present with preterm
                            contractions known as threatened premature labour (TPTL) progress to actual labour and
                            delivery</p>
                        <p>Spontaneous preterm labor, a syndrome caused by multiple pathologic processes, contributes to
                            about 70% of preterm deliveries.</p>
                    </div>
                </section>
                <!-- END: preterm-labor-definition -->

                <!-- START: preterm-labor-causes -->
                <section id="preterm-labor-causes" class="content-section">
                    <h2>Causes of preterm labour</h2>
                    <div class="content-card">
                        <h3>Maternal causes</h3>
                        <p>Demographic factors:</p>
                        <ul class="enhanced-list">
                            <li>Maternal age &lt;18 years and &gt;35 years</li>
                            <li>Maternal weight &lt;55 kg</li>
                            <li>Uterine distortion due to: m√ºllerian duct abnormalities, fibroids</li>
                            <li>Cervical incompetence due to: trauma, cone biopsy</li>
                            <li>Infection e.g., chorioamnionitis, UTI</li>
                            <li>Physical injury</li>
                            <li>History of spontaneous preterm birth</li>
                            <li>Hormonal imbalances</li>
                        </ul>

                        <h3>Pregnancy/ fetal causes</h3>
                        <ul class="enhanced-list">
                            <li>Preterm pre-labour rupture of membranes in current pregnancy</li>
                            <li>Antepartum hemorrhage</li>
                            <li>Uterine over distension due to multi-fetal gestation or poly-hydramnios</li>
                            <li>Fetal anomaly</li>
                            <li>Utero-placental insufficiency (e.g., hypertension, insulin-dependent diabetes, drug
                                abuse, smoking&gt;10 cigarettes/day, alcohol consumption)</li>
                        </ul>
                    </div>
                </section>
                <!-- END: preterm-labor-causes -->

                <!-- START: key-recommendations -->
                <section id="key-recommendations" class="content-section">
                    <h2>Summary of key recommendations</h2>
                    <div class="content-card">
                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 25: Recommendations of interventions to improve preterm birth outcomes
                                </caption>
                                <thead>
                                    <tr>
                                        <th>Maternal Interventions</th>
                                        <th>Recommendations</th>
                                        <th>Strength of recommendation and quality of the evidence</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Antenatal corticosteroids to Improve newborn outcomes</td>
                                        <td>1.0. Antenatal corticosteroid therapy is recommended for women at risk of
                                            preterm birth from 24 weeks to 34 weeks of gestation when the following
                                            conditions are met:
                                            <ul>
                                                <li>gestational age assessment can be accurately undertaken;</li>
                                                <li>preterm birth is considered imminent;</li>
                                                <li>there is no clinical evidence of maternal infection;</li>
                                                <li>adequate childbirth care is available (including the capacity to
                                                    recognize and safely manage preterm labour and birth);</li>
                                                <li>the preterm newborn can receive adequate care if needed (including
                                                    resuscitation, thermal care, feeding support, infection treatment
                                                    and safe oxygen use).</li>
                                            </ul>
                                        </td>
                                        <td>Strong recommendation based on moderate-quality evidence for newborn
                                            outcomes and low-quality evidence for maternal outcomes</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>1.1. For eligible women, antenatal corticosteroid should be administered
                                            when preterm birth is considered imminent within 7 days of starting
                                            treatment, including within the first 24 hours.</td>
                                        <td>Strong recommendation based on low-quality evidence</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>1.2. Antenatal corticosteroid therapy is recommended for women at risk of
                                            preterm birth irrespective of whether a single or multiple birth is
                                            anticipated.</td>
                                        <td>Strong recommendation based on low-quality evidence</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>1.3. Antenatal corticosteroid therapy is recommended in women with preterm
                                            prelabour rupture of membranes and no clinical signs of infection.</td>
                                        <td>Strong recommendation based on moderate-quality evidence for newborn
                                            outcomes and low-quality evidence for maternal outcomes</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>1.4. Antenatal corticosteroid therapy is not recommended in women with
                                            chorioamnionitis who are likely to deliver preterm.</td>
                                        <td>Conditional recommendation based on very low-quality evidence</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>1.5. Antenatal corticosteroid therapy is not recommended in women undergoing
                                            planned caesarean section at late preterm gestations ($34-36^{+6}$ weeks).
                                        </td>
                                        <td>Conditional recommendation based on very low-quality evidence</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>1.6. Antenatal corticosteroid therapy is recommended in women with
                                            hypertensive disorders in pregnancy who are at risk of imminent preterm
                                            birth.</td>
                                        <td>Strong recommendation based on moderate-quality evidence for newborn
                                            outcomes and low-quality evidence for maternal outcomes</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>1.7. Antenatal corticosteroid therapy is recommended for women at risk of
                                            imminent preterm birth of a growth-restricted fetus.</td>
                                        <td>Strong recommendation based on very low-quality evidence</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>1.8. Antenatal corticosteroid therapy is recommended for women with
                                            pre-gestational and gestational diabetes who are at risk of imminent preterm
                                            birth, and this should be accompanied by interventions to optimize maternal
                                            blood glucose control.</td>
                                        <td>Strong recommendation based on very low-quality evidence</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>1.9. Either intramuscular (IM) dexamethasone or IM betamethasone (total 24
                                            mg in divided doses) is recommended as the antenatal corticosteroid of
                                            choice when preterm birth is imminent.</td>
                                        <td>Strong recommendation based on low-quality evidence</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>1.10. A single repeat course of antenatal corticosteroid is recommended if
                                            preterm birth does not occur within 7 days after the initial dose, and a
                                            subsequent clinical assessment demonstrates that there is a high risk of
                                            preterm birth in the next 7 days.</td>
                                        <td>Conditional recommendation based on moderate-quality evidence for newborn
                                            outcomes and low-quality evidence for maternal outcomes</td>
                                    </tr>
                                    <tr>
                                        <td>Tocolytics for Inhibiting preterm labour</td>
                                        <td>2.0. Tocolytic treatments (acute and maintenance treatments) are not
                                            recommended for women at risk of imminent preterm birth for the purpose of
                                            improving newborn outcomes.</td>
                                        <td>Conditional recommendation based on very low-quality evidence</td>
                                    </tr>
                                    <tr>
                                        <td>Magnesium sulfate for fetal protection against neurological complications
                                        </td>
                                        <td>3.0. The use of magnesium sulfate is recommended for women at risk of
                                            imminent preterm birth before 32 weeks of gestation for prevention of
                                            cerebral palsy in the infant and child.</td>
                                        <td>Strong recommendation based on moderate-quality evidence</td>
                                    </tr>
                                    <tr>
                                        <td>Antibiotics for preterm labour</td>
                                        <td>4.0. Routine antibiotic administration is not recommended for women in
                                            preterm labour with intact amniotic membranes and no clinical signs of
                                            infection.</td>
                                        <td>Strong recommendation based on moderate-quality evidence</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>5.0. Antibiotic administration is recommended for women with preterm
                                            prelabour rupture of membranes.</td>
                                        <td>Strong recommendation based on moderate-quality evidence</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>5.1. Erythromycin is recommended as the antibiotic of choice for prophylaxis
                                            in women with preterm prelabour rupture of membranes.</td>
                                        <td>Conditional recommendation based on moderate-quality evidence</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>5.2. The use of a combination of amoxicillin and clavulanic acid
                                            ("co-amoxiclav") is not recommended for women with preterm prelabour rupture
                                            of membranes.</td>
                                        <td>Strong recommendation based on moderate-quality evidence</td>
                                    </tr>
                                    <tr>
                                        <td>Optimal mode of delivery</td>
                                        <td>6.0. Routine delivery by caesarean section for the purpose of improving
                                            preterm newborn outcomes is not recommended, regardless of cephalic or
                                            breech presentation.</td>
                                        <td>Conditional recommendation based on very low-quality evidence</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </section>
                <!-- END: key-recommendations -->

                <!-- START: prevention-preterm-labor -->
                <section id="prevention-preterm-labor" class="content-section">
                    <h2>Prevention of Preterm Labour and Delivery</h2>
                    <div class="content-card">
                        <h3>Progesterone Therapy</h3>
                        <p>In women with single gestation pregnancy and a history of spontaneous preterm delivery,
                            antenatal progesterone therapy is the most effective strategy to decrease the risk of a
                            recurrent preterm delivery. Progesterone supplementation is beneficial in these women
                            starting at 16 to 24 weeks' gestation and continuing through 34 weeks' gestation.</p>
                        <p>Two types of progesterone therapy are currently in use for the prevention of preterm
                            delivery. They include a weekly intramuscular injection of 17-alpha hydroxyprogesterone
                            caproate or medroxy progesterone acetate 5 mg tablet and daily administration of natural
                            micronized progesterone vaginal gel, vaginal suppository, or oral capsule.</p>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 26: Illustrating progesterone administration for prevention of preterm
                                    birth</caption>
                                <thead>
                                    <tr>
                                        <th>Type</th>
                                        <th>Route</th>
                                        <th>Dose (mg)</th>
                                        <th>Interval</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>17$\alpha$-OHPC</td>
                                        <td>Intramuscular injection</td>
                                        <td>250</td>
                                        <td>Weekly</td>
                                    </tr>
                                    <tr>
                                        <td>Natural micronized progesterone</td>
                                        <td>Vaginal suppository</td>
                                        <td>100, 200, 400</td>
                                        <td>Daily</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Vaginal gel</td>
                                        <td>90</td>
                                        <td>Daily</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Oral capsule</td>
                                        <td>200, 400</td>
                                        <td>Daily</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <p><em>17$\alpha$-OHPC, 17-alpha hydroxyprogesterone caproate.</em></p>

                        <h3>Cervical Cerclage and Pessary</h3>
                        <p>Cervical cerclage, an encircling suture placed around the cervix before or during pregnancy,
                            has been used to help correct structural defects or cervical weakening in high-risk women
                            with a shortened cervix.</p>
                        <p>Studies have shown that cerclage is associated with a decrease in preterm delivery and in
                            perinatal death when used in women with a prior preterm delivery and a cervical length of 25
                            mm or less.</p>

                        <h4>Guidance on evaluation and management of a shortened cervical length (CL)</h4>
                        <ul class="enhanced-list">
                            <li>CL should be confirmed using a standardized technique, with the TV US being the current
                                gold standard.</li>
                            <li>A multidisciplinary team approach should be initiated, with involvement of an
                                obstetrician and neonatologist to discuss risks of PTB if the patient is found to have a
                                short cervix.</li>
                            <li>Repeat TV US in 1-2 weeks, or consider commencement of progesterone for a CL of 20-25
                                mm.</li>
                            <li>Progesterone should be offered for prevention of PTB in women at low risk if CL is
                                &lt;20 mm at 18-22 weeks.</li>
                            <li>For women deemed to be high risk, cervical cerclage should be considered if there is
                                cervical dilatation pre-viability or if the cervix continues to shorten during
                                surveillance.</li>
                            <li>Progesterone is generally the preferred treatment because of the lower risk of surgical
                                complications.</li>
                        </ul>

                        <h3>Other prevention methods of preterm births</h3>
                        <ul class="enhanced-list">
                            <li>Preconception care package, including immediate post pregnancy family planning (e.g.,
                                Birth spacing and adolescent friendly services), education and nutrition especially for
                                girls, and STI prevention</li>
                            <li>Antenatal care packages for all women, including screening for and management of STIs,
                                high blood pressure and diabetes; behavior change for lifestyle risks; and targeted care
                                of women at increased risk of preterm birth</li>
                            <li>Provider education to promote appropriate induction and caesarean section.</li>
                            <li>Policy support including smoking cessation and employment safeguards of pregnant women
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: prevention-preterm-labor -->

                <!-- START: diagnosis-management -->
                <section id="diagnosis-management" class="content-section">
                    <h2>Diagnosis</h2>
                    <div class="content-card">
                        <h3>Assessment in a woman with suspected preterm labor</h3>
                        <ul class="enhanced-list">
                            <li><strong>Establish dates:</strong>
                                <ul>
                                    <li>Review history of pregnancy (estimated date of delivery, menstrual history,
                                        ultrasounds)</li>
                                    <li>Examine the prenatal record for menstrual history, estimated date of delivery,
                                        information from dating ultrasound, and clinical growth</li>
                                </ul>
                            </li>
                            <li><strong>Evaluate contractions:</strong>
                                <ul>
                                    <li>History (frequency, intensity, duration, changes with time)</li>
                                    <li>Abdominal examination for uterine activity using a tocodynamometer, if available
                                    </li>
                                </ul>
                            </li>
                            <li><strong>Cervical assessment:</strong>
                                <ul>
                                    <li>Sterile speculum exam initially to rule out preterm pre-labor rupture of
                                        membranes (PPROM) and to obtain cultures</li>
                                    <li>If indicated digital examination can be performed after premature rupture of
                                        membranes is ruled out for the purposes of determining cervical position,
                                        dilatation and effacement.</li>
                                </ul>
                            </li>
                        </ul>
                        <p>NB: Women should be instructed early in their antepartum care to be vigilant for signs and
                            symptoms of impending preterm labour and to contact their health care provider or go to
                            their health care facility. Signs and symptoms may include:</p>
                        <ul class="enhanced-list">
                            <li>Contractions</li>
                            <li>Vaginal fluid loss</li>
                            <li>Vaginal bleeding</li>
                            <li>Maternal perception of changes in pelvic pressure, low dull backache, or vaginal
                                discharge</li>
                        </ul>
                        <p>Clinical suspicion should be raised by the presence of uterine contractions combined with a
                            cervical examination suggesting early dilation and/or effacement. This approach facilitates
                            early institution of therapy but results in a 50% over-diagnosis of preterm labor (PTL).</p>

                        <h3>Investigations</h3>
                        <p>Initial investigations include:</p>
                        <ul class="enhanced-list">
                            <li>Non-stress cardiotocogram</li>
                            <li>Tocography</li>
                            <li>Trans-vaginal ultrasound of the cervix</li>
                            <li>Cervico-vaginal swab for fetal fibronectin</li>
                        </ul>
                        <p>Other investigations to consider:</p>
                        <ul class="enhanced-list">
                            <li>Nitrazine test</li>
                            <li>Microscopy, culture and sensitivity of vaginal fluid</li>
                            <li>Kleihauer-Betke blood test</li>
                            <li>Urine toxicology screen</li>
                            <li>TORCH (toxoplasmosis, other infections i.e. syphilis, rubella, cytomegalovirus
                                infection, herpes simplex)</li>
                            <li>Immunoglobulin (IgG and IgM) screening whenever historical or clinical suspicion is
                                present.</li>
                        </ul>
                        <p>In patients with a history of mid-trimester loss, laboratory tests for risk assessment
                            include:</p>
                        <ul class="enhanced-list">
                            <li>Rapid plasma reagin test</li>
                            <li>Gonorrhea and chlamydia screening</li>
                            <li>Vaginal pH/wet smear/whiff test</li>
                            <li>Anticardiolipin antibody (e.g., anticardiolipin immunoglobulin [Ig] G and IgM ,
                                anti-beta2 microglobulin)</li>
                            <li>Lupus anticoagulant antibody</li>
                            <li>Activated partial thromboplastin time</li>
                            <li>One-hour glucose challenge test</li>
                        </ul>

                        <h3>Management of preterm labour</h3>
                        <h4>Prolongation of pregnancy</h4>
                        <p>No intervention has been shown to reduce the incidence of preterm birth. However, tocolysis
                            has been shown to prolong pregnancy for 48 hours or more.</p>
                        <p>This provides the window of opportunity for the administration and absorption of
                            corticosteroids. It also allows for the transportation of the woman to a tertiary center if
                            necessary.</p>
                        <p>Tocolytic treatments (acute and maintenance treatments) are not recommended for women at risk
                            of imminent preterm birth for the purpose of improving newborn outcomes.</p>

                        <h4>Contraindications to Tocolysis</h4>
                        <p>In a significant percentage of women in preterm labor, tocolysis may be contraindicated:</p>
                        <ul class="enhanced-list">
                            <li>Gestational hypertension with proteinuria or other medical indication</li>
                            <li>Chorioamnionitis</li>
                            <li>Mature fetus</li>
                            <li>Imminent delivery</li>
                            <li>Intrauterine fetal death or lethal fetal abnormality</li>
                        </ul>

                        <h4>Antenatal corticosteroid therapy</h4>
                        <p>Dexamethasone and betamethasone cross the placenta and induce enzymes that accelerate fetal
                            pulmonary maturity. It takes 48 hours after the first dose for the full benefit to be
                            achieved.</p>
                        <p>Four doses of dexamethasone (6 mg IM) 12 hours apart are recommended for acceleration of
                            fetal lung maturity. Alternatively, two doses of betamethasone (12 mg IM) 24 hours apart can
                            be used.</p>
                        <p>Antenatal corticosteroid therapy is recommended for women at risk of preterm birth from 24
                            weeks to 34 weeks of gestation when the following conditions are met:</p>
                        <ul class="enhanced-list">
                            <li>Gestational age assessment can be accurately undertaken;</li>
                            <li>Preterm birth is considered imminent;</li>
                            <li>There is no clinical evidence of maternal infection;</li>
                            <li>Adequate childbirth care is available (including the capacity to recognize and safely
                                manage preterm labour and birth);</li>
                            <li>The preterm newborn can receive adequate care if needed (including resuscitation,
                                thermal care, feeding support, infection treatment and safe oxygen use).</li>
                        </ul>

                        <h4>Mode of delivery</h4>
                        <p>Routine delivery by caesarean section for the purpose of improving preterm newborn outcomes
                            is not recommended, regardless of cephalic or breech presentation. Caesarean section should
                            only be performed for obstetric indications. (Conditional recommendation based on very
                            low-quality evidence).</p>
                        <p>Pertaining to the following interventions, there is no evidence of any benefit. However,
                            there may not have been sufficient studies to evaluate the effectiveness of some of these
                            interventions:</p>
                        <ul class="enhanced-list">
                            <li>Bed rest</li>
                            <li>Fluid bolus</li>
                            <li>Sedation, narcotics</li>
                            <li>Home uterine activity monitoring</li>
                        </ul>

                        <figure>
                            <img src="../assets/images/2025_11_24_1f5d3abc0b734f89226ag-124-1.jpg"
                                alt="Figure 21: Algorithm for the assessment and management of preterm labour (12)"
                                class="content-image">
                            <figcaption>Figure 21: Algorithm for the assessment and management of preterm labour (12)
                            </figcaption>
                        </figure>

                        <figure>
                            <img src="../assets/images/2025_11_24_1f5d3abc0b734f89226ag-125-1.jpg"
                                alt="Figure 22: Algorithm of management of preterm labour (13)" class="content-image">
                            <figcaption>Figure 22: Algorithm of management of preterm labour (13)</figcaption>
                        </figure>

                        <p>Options for antenatal corticosteroids not shown in the algorithms above that can be used
                            based on availability include:</p>
                        <ul class="enhanced-list">
                            <li>Dexamethasone 6 mg BD for 2 days (total 24 mg)</li>
                        </ul>
                        <p>Other options for tocolysis not shown in the algorithms above that can be used based on
                            availability include:</p>
                        <ul class="enhanced-list">
                            <li>Magnesium sulphate which has the added advantage of neuroprotection. it is given at a
                                dose of 4 g IV over 15 to 20 minutes then 1 g/hour for 24 hours</li>
                            <li>Beta blockers: Ritodrine 0.15 mg IV bolus or Terbutaline subcutaneously (0.25 mg every
                                20 minutes for max 3 doses (or 0.25 IV bolus)</li>
                            <li>Nitroglycerine 100-200 mcg intravenously</li>
                            <li>Atosiban (oxytocin receptor blocker) loading dose of IV 6.75 mg in 0.9 ml over one
                                minute plus 18 mg per hour for 3 hours. The maintenance dose is IV 6 mg per hour will be
                                given for up to 45 hours, or until contractions have stopped.</li>
                            <li>Indomethacin orally 50-100 mg loading dose then 25-50 mg every 4 hours for 48 hours
                                (Indomethacin, an NSAID, should not be used after 32 weeks gestation as it can cause
                                premature closure of the ductus arteriosus).</li>
                        </ul>
                    </div>
                </section>
                <!-- END: diagnosis-management -->

                <!-- START: preterm-birth -->
                <section id="preterm-birth" class="content-section">
                    <h1 class="section-title">PRETERM BIRTH</h1>
                    <div class="content-card">
                        <h2>Definition</h2>
                        <p>This is the birth that occurs between 24- and 37-weeks' gestation. In two-thirds of cases it
                            occurs following spontaneous onset of labour. Only a minority of women who present with
                            preterm contractions known as threatened premature labour (TPTL) progress to actual labour
                            and delivery.</p>
                        <p>Spontaneous preterm labor, a syndrome caused by multiple pathologic processes, contributes to
                            about 70% of preterm deliveries.</p>
                        <p>The risk of preterm deliveries increases with low social-economic status. Countries with the
                            highest rates of preterm deliveries also report that these deliveries occur in persons of
                            lower socioeconomic status.</p>
                        <p>Preterm birth is the leading cause of mortality in children under the age of 5 with the
                            incidence increasing in babies of lower gestational ages.</p>

                        <h2>Epidemiology</h2>
                        <p>Yearly, an estimated 15 million babies are born preterm (before 37 completed weeks) with 60%
                            of this happening in Africa and South Asia.</p>
                        <p>The rate of preterm births in countries analyzed in the WHO Global Action report ranged
                            between 5 - 18% with Kenya having an estimated range of between 10 - 15%.</p>
                        <p>A study at the Kenyatta National Referral Hospital in Kenya in 2018 put the prevalence at the
                            institution at 18.3%.</p>

                        <h3>Recommendations on preterm births/deliveries</h3>
                        <ul class="enhanced-list">
                            <li>Deferring delivery to the 39th week is not recommended if there is a medical or
                                obstetric indication for earlier delivery.</li>
                            <li>Recommendations for the timing of delivery for a number of specific conditions (Table 1)
                            </li>
                            <li>In the case of an anticipated late-preterm delivery a single course of antenatal
                                betamethasone is recommended within 7 days of delivery in select women who have not
                                received a previous course of antenatal corticosteroids.</li>
                            <li>However, a medically indicated late-preterm delivery should not be delayed for the
                                administration of antenatal corticosteroids</li>
                            <li>The decisions regarding delivery timing are complex and must take into account relative
                                maternal and new-born risks, practice environment, and patient preferences.</li>
                            <li>Secondly, late-preterm or early-term deliveries may be required for maternal benefit or
                                new-born benefit, or both.</li>
                            <li>In these cases, health care providers will need to weigh competing risks and benefits
                                for the woman and her fetus and the support at the level of health facility adequate or
                                referral mechanisms provided prior to delivery decision.</li>
                        </ul>

                        <h3>Mandatory Responsibility for health Care Providers</h3>
                        <ul class="enhanced-list">
                            <li>Prepare the mother and partner for the outcome of the pregnancy</li>
                            <li>Prepare resuscitation equipment</li>
                            <li>Prepare the environment and alert NBU</li>
                        </ul>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 1. Recommendations for the Timing of Delivery When Conditions Complicate
                                    Pregnancy*</caption>
                                <thead>
                                    <tr>
                                        <th>Condition</th>
                                        <th>General Timing</th>
                                        <th>Suggested Specific Timing</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td colspan="3"><strong>Placental/Uterine Conditions</strong></td>
                                    </tr>
                                    <tr>
                                        <td>Placenta previa</td>
                                        <td>Late preterm/early term</td>
                                        <td>$36\ 0/7 - 37\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Suspected accreta, increta, or percreta</td>
                                        <td>Late preterm</td>
                                        <td>$34\ 0/7 - 35\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Vasa previa</td>
                                        <td>Late preterm/early term</td>
                                        <td>$34\ 0/7 - 37\ 0/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Prior classical cesarean</td>
                                        <td>Late preterm/early term</td>
                                        <td>$36\ 0/7 - 37\ 0/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Prior myomectomy requiring cesarean delivery</td>
                                        <td>Early term (individualize)</td>
                                        <td>$37\ 0/7 - 38\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Previous uterine rupture</td>
                                        <td>Late preterm/early term</td>
                                        <td>$36\ 0/7 - 37\ 0/7$ weeks gestation</td>
                                    </tr>
                                    <tr>
                                        <td colspan="3"><strong>Fetal Conditions</strong></td>
                                    </tr>
                                    <tr>
                                        <td>Oligohydramnios (isolated or otherwise uncomplicated [deepest vertical
                                            pocket less than 2 cm])</td>
                                        <td>Late preterm/early term</td>
                                        <td>$36\ 0/7 - 37\ 6/7$ weeks of gestation or at diagnosis if diagnosed later
                                        </td>
                                    </tr>
                                    <tr>
                                        <td>Polyhydramnios</td>
                                        <td>Full term</td>
                                        <td>$39\ 0/7 - 39\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td colspan="3"><strong>Growth restriction (singleton)</strong></td>
                                    </tr>
                                    <tr>
                                        <td>Otherwise uncomplicated, no concurrent findings</td>
                                        <td>Early term/full term</td>
                                        <td>$38\ 0/7 - 39\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Abnormal umbilical artery dopplers: elevated S/D ratio with diastolic flow
                                        </td>
                                        <td>Early term</td>
                                        <td>Consider at $37\ 0/7$ weeks of gestation or at diagnosis if diagnosed later
                                        </td>
                                    </tr>
                                    <tr>
                                        <td>Abnormal umbilical artery dopplers: absent end diastolic flow</td>
                                        <td>Late preterm</td>
                                        <td>Consider at $34\ 0/7$ weeks of gestation or at diagnosis if diagnosed later
                                        </td>
                                    </tr>
                                    <tr>
                                        <td>Abnormal umbilical artery dopplers: reversed end diastolic flow</td>
                                        <td>Preterm</td>
                                        <td>Consider at $32\ 0/7$ weeks of gestation or at diagnosis if diagnosed later
                                        </td>
                                    </tr>
                                    <tr>
                                        <td>Concurrent conditions (oligohydramnios, maternal comorbidity [eg,
                                            preeclampsia, chronic hypertension])</td>
                                        <td>Late preterm/early term</td>
                                        <td>$34\ 0/7 - 37\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td colspan="3"><strong>Multiple gestations-uncomplicated</strong></td>
                                    </tr>
                                    <tr>
                                        <td>Dichorionic-diamniotic twins</td>
                                        <td>Early term</td>
                                        <td>$38\ 0/7 - 38\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Monochorionic-diamniotic twins</td>
                                        <td>Late preterm/early term</td>
                                        <td>$34\ 0/7 - 37\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Monochorionic-monoamniotic twins</td>
                                        <td>Preterm/late preterm</td>
                                        <td>$32\ 0/7 - 34\ 0/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Triplet and higher order</td>
                                        <td>Preterm/late preterm</td>
                                        <td>Individualized</td>
                                    </tr>
                                    <tr>
                                        <td colspan="3"><strong>Multiple gestations-complicated</strong></td>
                                    </tr>
                                    <tr>
                                        <td>Dichorionic-diamniotic twins with isolated fetal growth restriction</td>
                                        <td>Late preterm/early term</td>
                                        <td>$36\ 0/7 - 37\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Dichorionic-diamniotic twins with concurrent condition</td>
                                        <td>Late preterm</td>
                                        <td>Individualized</td>
                                    </tr>
                                    <tr>
                                        <td>Monochorionic-diamniotic twins with isolated fetal growth restriction</td>
                                        <td>Preterm/late preterm</td>
                                        <td>$32\ 0/7 - 34\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td colspan="3"><strong>Alloimmunization</strong></td>
                                    </tr>
                                    <tr>
                                        <td>At-risk pregnancy not requiring intrauterine transfusion</td>
                                        <td>Early term</td>
                                        <td>$37\ 0/7 - 38\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Requiring intrauterine transfusion</td>
                                        <td>Late preterm or early term</td>
                                        <td>Individualized</td>
                                    </tr>
                                    <tr>
                                        <td colspan="3"><strong>Maternal Conditions</strong></td>
                                    </tr>
                                    <tr>
                                        <td colspan="3"><strong>Hypertensive disorders of pregnancy</strong></td>
                                    </tr>
                                    <tr>
                                        <td>Chronic hypertension: isolated, uncomplicated, controlled, not requiring
                                            medications</td>
                                        <td>Early term/full term</td>
                                        <td>$38\ 0/7 - 39\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Chronic hypertension: isolated, uncomplicated, controlled on medications
                                        </td>
                                        <td>Early term/full term</td>
                                        <td>$37\ 0/7 - 39\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Chronic hypertension: difficult to control (requiring frequent medication
                                            adjustments)</td>
                                        <td>Late preterm/early term</td>
                                        <td>$36\ 0/7 - 37\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Gestational hypertension, without severe-range blood pressure</td>
                                        <td>Early term</td>
                                        <td>$37\ 0/7$ weeks or at diagnosis if diagnosed later</td>
                                    </tr>
                                    <tr>
                                        <td>Gestational hypertension with severe-range blood pressures</td>
                                        <td>Late preterm</td>
                                        <td>$34\ 0/7$ weeks of gestation or at diagnosis if diagnosed later</td>
                                    </tr>
                                    <tr>
                                        <td>Preeclampsia without severe features</td>
                                        <td>Early term</td>
                                        <td>$37\ 0/7$ weeks of gestation or at diagnosis if diagnosed later</td>
                                    </tr>
                                    <tr>
                                        <td>Preeclampsia with severe features, stable maternal and fetal conditions,
                                            after fetal viability (includes superimposed)</td>
                                        <td>Late preterm</td>
                                        <td>$34\ 0/7$ weeks of gestation or at diagnosis if diagnosed later</td>
                                    </tr>
                                    <tr>
                                        <td>Preeclampsia with severe features, unstable or complicated, after fetal
                                            viability (includes superimposed and HELLP)</td>
                                        <td>Soon after maternal stabilization</td>
                                        <td>Soon after maternal stabilization</td>
                                    </tr>
                                    <tr>
                                        <td>Preeclampsia with severe features, before viability</td>
                                        <td>Soon after maternal stabilization</td>
                                        <td>Soon after maternal stabilization</td>
                                    </tr>
                                    <tr>
                                        <td colspan="3"><strong>Diabetes</strong></td>
                                    </tr>
                                    <tr>
                                        <td>Pregestational diabetes well-controlled</td>
                                        <td>Full term</td>
                                        <td>$39\ 0/7 - 39\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Pregestational diabetes with vascular complications, poor glucose control,
                                            or prior stillbirth</td>
                                        <td>Late preterm/early term</td>
                                        <td>$36\ 0/7 - 38\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Gestational: well controlled on diet and exercise</td>
                                        <td>Full term</td>
                                        <td>$39\ 0/7 - 40\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Gestational: well controlled on medications</td>
                                        <td>Full term</td>
                                        <td>$39\ 0/7 - 39\ 6/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Gestational: poorly controlled</td>
                                        <td>Late preterm/early term</td>
                                        <td>Individualized</td>
                                    </tr>
                                    <tr>
                                        <td colspan="3"><strong>HIV</strong></td>
                                    </tr>
                                    <tr>
                                        <td>Intact membranes and viral load > 1,000 copies/mL</td>
                                        <td>Early-term cesarean delivery</td>
                                        <td>$38\ 0/7$ weeks of gestation</td>
                                    </tr>
                                    <tr>
                                        <td>Viral load $\leq$ 1,000 copies/ml with antiretroviral therapy</td>
                                        <td>Full term (early term birth not indicated)</td>
                                        <td>$39\ 0/7$ weeks of gestation or later</td>
                                    </tr>
                                    <tr>
                                        <td>Intrahepatic cholestasis of pregnancy</td>
                                        <td>Late preterm/early term</td>
                                        <td>$36\ 0/7 - 37\ 0/7$ weeks of gestation or at diagnosis if diagnosed later
                                        </td>
                                    </tr>
                                    <tr>
                                        <td colspan="3"><strong>Obstetric Conditions</strong></td>
                                    </tr>
                                    <tr>
                                        <td>Preterm PROM</td>
                                        <td>Late preterm</td>
                                        <td>$34\ 0/7$ weeks of gestation or at diagnosis if diagnosed later</td>
                                    </tr>
                                    <tr>
                                        <td>PROM ($37\ 0/7$ weeks of gestation and beyond)</td>
                                        <td>Generally, at diagnosis</td>
                                        <td>Generally, at diagnosis</td>
                                    </tr>
                                    <tr>
                                        <td>Previous stillbirth</td>
                                        <td>Full term (early term birth not routinely recommended)</td>
                                        <td>Individualized</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>

                        <h3>Classification and etiology of preterm labour</h3>
                        <p>Preterm birth can be termed as a syndrome with a variety of causes which can be classified
                            into two broad subtypes:</p>
                        <ul class="enhanced-list">
                            <li><strong>Spontaneous preterm birth</strong> - spontaneous onset of labor or following
                                pre-labor premature rupture of membranes (PPROM)</li>
                            <li><strong>Provider-initiated preterm birth</strong> - defined as induction of labor or
                                elective caesarian birth before 37 completed weeks of gestation for maternal or fetal
                                indications that could be urgent or discretionary or not related to any medical
                                conditions</li>
                        </ul>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 28: Classifying and illustrating the contributors to preterm birth
                                </caption>
                                <thead>
                                    <tr>
                                        <th>Type:</th>
                                        <th>Risk Factors:</th>
                                        <th>Examples:</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Spontaneous preterm birth:</td>
                                        <td>Age at pregnancy and pregnancy spacing</td>
                                        <td>Adolescent pregnancy, advanced maternal age, or short interpregnancy
                                            interval</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Multiple pregnancy</td>
                                        <td>Increased rates of twin and higher order pregnancies with assisted
                                            reproduction</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Infection</td>
                                        <td>Urinary tract infections, malaria, HIV, syphilis, bacterial vaginosis,</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Underlying maternal chronic medical conditions</td>
                                        <td>Diabetes, hypertension, anaemia, asthma, thyroid disease</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Nutritional</td>
                                        <td>Undernutrition, obesity, micronutrient deficiencies</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Lifestyle/ work related</td>
                                        <td>Smoking, excess alcohol consumption, recreational drug use, excess physical
                                            work/activity</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Maternal psychological health</td>
                                        <td>Depression, violence against women</td>
                                    </tr>
                                    <tr>
                                        <td></td>
                                        <td>Genetic and other</td>
                                        <td>Genetic risk, e.g., family history Cervical incompetence</td>
                                    </tr>
                                    <tr>
                                        <td>Provider-initiated preterm birth:</td>
                                        <td>Medical induction or cesarean birth for: obstetric indication Fetal
                                            indication Other - Not medically indicated</td>
                                        <td>There is an overlap for indicated provider-initiated preterm birth with the
                                            risk factors for spontaneous preterm birth</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>

                        <p>Babies born preterm are further categorized based on their gestational age as follows:</p>
                        <ul class="enhanced-list">
                            <li>Extremely preterm (less than 28 weeks)</li>
                            <li>Very preterm (28 to 32 weeks)</li>
                            <li>Moderate to late preterm (32 to 37 weeks)</li>
                        </ul>
                        <p>Other than the gestational age, babies can also be categorized based on their birth weight.
                            For preterm births, birth weight is a big determinant on the kind and quality of care needed
                            to ensure survival. This categorization is as follows:</p>
                        <ul class="enhanced-list">
                            <li>Extreme Low Birth Weight (&lt; 1,000 g)</li>
                            <li>Very Low Birth Weight (&lt; 1,500 g)</li>
                            <li>Low Birth Weight (&lt; 2,500 g)</li>
                            <li>Normal Birth Weight (&lt; 4,000 g)</li>
                            <li>High Birth Weight (&gt; 4,000 g)</li>
                        </ul>

                        <h3>Complications associated with preterm birth</h3>
                        <h4>Neonatal risks</h4>
                        <ul class="enhanced-list">
                            <li>Feeding difficulties in babies less than 34 weeks of gestation since the coordinated
                                suck and swallow process only starts at 34weeks gestation.</li>
                            <li>Severe infections are more common with increased chances of neonatal sepsis.</li>
                            <li>Respiratory Distress Syndrome due to lung immaturity and lack of surfactant in the
                                alveoli, resulting in collapsing lungs that take extra pressure to inflate.</li>
                            <li>Jaundice is more common in premature babies since the immature liver cannot easily
                                metabolize bilirubin.</li>
                            <li>Brain injury in preterm babies is most commonly intra-ventricular hemorrhage.</li>
                            <li>Necrotizing enterocolitis. Formula feeding increases the risk ten-fold compared to
                                babies who are fed breast milk alone</li>
                            <li>Retinopathy of prematurity due to abnormal proliferation of the blood vessels around the
                                retina of the eye.</li>
                            <li>Anemia of prematurity</li>
                        </ul>

                        <h4>Maternal risks</h4>
                        <ul class="enhanced-list">
                            <li>Risk of preterm deliveries in subsequent pregnancies</li>
                            <li>Mental distress</li>
                            <li>Increased hospital stays</li>
                        </ul>

                        <h3>Preterm Birth in Multiple Gestation</h3>
                        <p>Twin pregnancies are associated with a three-fold greater perinatal mortality than singleton
                            pregnancies. Prematurity is a main contributor, with 50% of twin pregnancies delivering
                            before 37 weeks and 10% delivering before 32 weeks of gestation. The etiology of preterm
                            delivery in twin pregnancies is likely multifactorial and different from that of singletons.
                        </p>
                        <p>Cervical cerclage reduces preterm birth rates in singletons but has mixed results in twins
                            with some studies showing harm.</p>
                        <p>The use of progesterone to prevent preterm birth in singletons has conflicting results and
                            has not been proven to prevent preterm birth in twins.</p>
                        <p>Studies continue to determine whether the cervical pessary is effective in preventing preterm
                            birth in multiple pregnancies.</p>
                        <p>There is a paucity of data available on the prevention of preterm birth in triplets/higher
                            order multiples but similar principles to twin pregnancy apply</p>

                        <h3>Care of the premature baby</h3>
                        <p>Care of the premature baby entails the following:</p>
                        <ul class="enhanced-list">
                            <li>Essential and extra newborn care, especially feeding support</li>
                            <li>Neonatal resuscitation</li>
                            <li>Kangaroo Mother Care</li>
                            <li>Chlorhexidine cord care</li>
                            <li>Management of premature babies with complications, especially respiratory distress
                                syndrome and infection</li>
                            <li>Comprehensive neonatal intensive care, where capacity allows</li>
                        </ul>

                        <h3>Kangaroo Mother Care (KMC)</h3>
                        <p>Kangaroo mother care is defined as care of preterm infants or infants weighing less than 2000
                            g carried skin-to-skin with the mother. It aims to promote the health and wellbeing of
                            infants born preterm or at term.</p>
                        <p>This method of care was developed in Colombia as an alternative method of care in resource
                            poor settings for preterm infants who had no underlying medical condition and only needed to
                            feed and grow.</p>
                        <p>Kangaroo mother care can either be:</p>
                        <ul class="enhanced-list">
                            <li><strong>Continuous:</strong> This is the recommended modality of care, in which the baby
                                is maintained on skin to skin contact with the mother full time except during times of
                                feeding and cleaning.</li>
                            <li><strong>Intermittent care:</strong> is recommended rather than conventional care in
                                instances where continuous kangaroo care is not possible.</li>
                        </ul>

                        <h4>When to start kangaroo care:</h4>
                        <p>At birth, preterm babies and those small for gestational age are expected to have certain
                            complications. These complications should be managed as per the institutions/ national
                            guidelines and once clinically stable then kangaroo mother care can be initiated. However,
                            in instances where no complications are present, kangaroo mother care can be initiated after
                            birth.</p>
                        <p>Birth weight ranges are given as guides for initiation as follows:</p>
                        <ul class="enhanced-list">
                            <li>Babies weighing 1800 g or more at birth (gestational age 30-34 weeks or more) may have
                                some prematurity-related problems, such as respiratory distress syndrome (RDS). This may
                                raise serious concerns for a minority of those infants, who will require care in special
                                units. In most cases, however, KMC can start soon after birth.</li>
                            <li>Babies with birth weight between 1200 and 1799g (gestational age 28-32 weeks),
                                prematurity related complications are expected and therefore initial management in
                                specialized units is needed and once the baby is stable, then kangaroo care can be
                                initiated, usually after a week or more depending on the severity of the complications.
                            </li>
                            <li>Babies weighing less than 1200 g (gestational age below 30 weeks) incur frequent and
                                severe problems due to preterm birth: mortality is very high and only a small proportion
                                survives prematurity-related problems. These babies benefit most from transfer before
                                birth to an institution with neonatal intensive care facilities. It may take weeks
                                before their condition allows initiation of KMC.</li>
                        </ul>

                        <h4>When to wean the baby off kangaroo care</h4>
                        <p>KMC tends to be used until the baby reaches term (gestational age around 40 weeks) or 2500 g.
                            Around that time the baby also outgrows the need for KMC. Certain subtle signs from the baby
                            indicate discomfort associated with skin to skin contact. At this point, it is recommended
                            that the mother weans the baby off KMC however; she can still use the method in instances of
                            extreme cold temperatures.</p>

                        <h4>Factors to consider when counselling the mother on KMC</h4>
                        <ul class="enhanced-list">
                            <li>Willingness: the mother must be willing to provide KMC;</li>
                            <li>Full-time availability to provide care: other family members can offer intermittent
                                skin-to-skin contact but they cannot breastfeed;</li>
                            <li>General health: if the mother suffered complications during pregnancy or delivery or is
                                otherwise ill, she should recover before initiating KMC;</li>
                            <li>Adequate support systems</li>
                        </ul>

                        <h4>Advantages of kangaroo mother care.</h4>
                        <ul class="enhanced-list">
                            <li>Early, continuous and prolonged skin-to-skin contact between the mother and the baby;
                            </li>
                            <li>Promotes exclusive breastfeeding</li>
                            <li>Can be carried out at home</li>
                            <li>Short hospital stays since babies pick up quickly</li>
                            <li>It is a gentle, effective method that avoids the agitation routinely experienced in a
                                busy ward with preterm infants.</li>
                            <li>Can be done by any member of the family including the father. This is especially useful
                                to assist the mother in taking breaks to rest.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: preterm-birth -->

            </main>

            <!-- Bottom Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">üè†</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="04-aph-and-pprom.html" class="nav-button">
                        <span class="nav-icon">‚Üê</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 27%;"></div>
                        </div>
                        <span class="progress-text">Section 5 of 18</span>
                    </div>
                    <a href="06-medical-disorders-hypertension.html" class="nav-button">
                        <span class="nav-text">Next: Hypertensive Disorders</span>
                        <span class="nav-icon">‚Üí</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>

</html>